Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study

• Main Authors: Baltazar Nunes (Author), James Humphreys (Author), Nathalie Nicolay (Author), Toon Braeye (Author), Izaak Van Evercooren (Author), Christian Holm Hansen (Author), Ida Rask Moustsen-Helms (Author), Chiara Sacco (Author), Massimo Fabiani (Author), Jesús Castilla (Author), Iván Martínez-Baz (Author), Hinta Meijerink (Author), Ausenda Machado (Author), Patricia Soares (Author), Rickard Ljung (Author), Nicklas Pihlström (Author), Anthony Nardone (Author), Sabrina Bacci (Author), Susana Monge (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background We aimed to estimate XBB.1.5 vaccine effectiveness (VE) against COVID-19-related hospitalizations and deaths during BA.2.86/JN.1 predominance, among EU/EEA individuals with ≥65-years.Research design and methods We linked electronic health records to create historical cohorts in Belgium, D...